Sawai Group (OTCMKTS:SWGHF – Get Free Report) will likely be posting its resultson Monday, August 10th. Analysts expect the company to post earnings of $0.2693 per share and revenue of $316.97 million for the quarter.
Sawai Group Price Performance
Shares of OTCMKTS:SWGHF remained flat at $12.03 during mid-day trading on Monday. The company’s 50 day moving average price is $12.03 and its 200 day moving average price is $12.03. Sawai Group has a 1 year low of $11.52 and a 1 year high of $12.03.
Sawai Group Company Profile
Sawai Group (OTCMKTS:SWGHF) is a Japan‐based pharmaceutical company primarily focused on the development, manufacturing and marketing of generic medications. Established in 1975 and headquartered in Osaka, Sawai Group has grown to become one of the leading producers of oral solid dosage forms in the Japanese market. The company’s product portfolio includes tablets, capsules and other formulations for chronic and acute indications, with an emphasis on cost‐effective alternatives to branded therapies.
At the core of Sawai Group’s operations is a vertically integrated manufacturing network that encompasses research and development, quality control and commercial production.
Read More
- Five stocks we like better than Sawai Group
- A Sweet Beat and a Wearables Rally Came With Reasons to Pause
- 3 Healthcare Stocks With Fresh Dividend Hikes and Different Income Profiles
- 3 Humanoid Robot ETFs to Ride a Speculative Trend
- Bearish Pressure Is Building Around These 3 Stocks
Receive News & Ratings for Sawai Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sawai Group and related companies with MarketBeat.com's FREE daily email newsletter.
